Health: Optical News

Today is March 19, 2024. All times in Eastern Daylight Time.

STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses

03/18/2024 - 07:00 AM

BUSINESS WIRE
Nordic Group B.V., par l’intermédiaire de sa filiale Nordic Pharma, Inc. (U.S.), nomme un chirurgien oculoplastique de renom, John P. Fezza, MD, au sein de son conseil consultatif médical

03/14/2024 - 06:53 PM

BUSINESS WIRE
OneLegacy Partnered with Danny Trejo and Trejo Music to Host SOULDIEZ Concert Featuring Talented Artists, Lowriders, Trejo’s Tacos and More

03/14/2024 - 05:55 PM

BUSINESS WIRE
Nordic Group B.V. ernennt über die Tochtergesellschaft Nordic Pharma, Inc. (USA) den anerkannten Augenchirurgen John P. Fezza, MD zum Mitglied des Medical Advisory Board

03/14/2024 - 05:52 PM

BUSINESS WIRE
Riassunto: Nordic Group B.V., tramite la sua affiliata Nordic Pharma, Inc. (U.S.), nomina il rinomato chirurgo oculoplastico John P. Fezza, MD, membro del Consiglio di consulenza medica

03/14/2024 - 02:19 PM

BUSINESS WIRE
Samenvatting: Via haar dochteronderneming Nordic Pharma, Inc. (U.S.) benoemt Nordic Group B.V. de vermaarde oculoplastische chirurg John P. Fezza, MD, tot lid van haar Medische Adviesraad

03/14/2024 - 02:15 PM

BUSINESS WIRE
Resumen: Nordic Group B.V. a través de su filial Nordic Pharma, Inc. (EE. UU.), nombra al prestigioso cirujano oculoplástico John P. Fezza, miembro de su Junta asesora médica

03/14/2024 - 02:15 PM

BUSINESS WIRE
Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Appoints Renowned Oculoplastic Surgeon, John P. Fezza, MD to Its Medical Advisory Board

03/14/2024 - 09:00 AM

BUSINESS WIRE
OcuTerra Announces Topline Data from Phase 2 DR:EAM Trial Evaluating Nesvategrast (OTT166 5%) for Patients with Diabetic Retinopathy

03/14/2024 - 08:00 AM

BUSINESS WIRE
NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023

03/14/2024 - 08:00 AM

BUSINESS WIRE
Surface Ophthalmics Announces New Leadership with Richard Lindstrom, MD, and Renewed Vision for Addressing Critical Unmet Needs of Dry Eye Syndrome Patients

03/13/2024 - 08:03 AM

BUSINESS WIRE
RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit

03/13/2024 - 08:00 AM

BUSINESS WIRE
National Vision Awards Trio of Optometry Students $12,500 in Ninth Annual Scholarship Program

03/12/2024 - 08:30 AM

BUSINESS WIRE
STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors

03/12/2024 - 07:00 AM

BUSINESS WIRE
US Eye Chief Medical Officer Dr. Kerry Solomon Honored with AECOS Award

03/12/2024 - 07:00 AM

BUSINESS WIRE
Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India

03/12/2024 - 04:30 AM

BUSINESS WIRE
GenSight Biologics Announces Initial Results from New Meta-Analyses on Visual Outcomes with LUMEVOQ® Gene Therapy at NANOS 2024

03/12/2024 - 02:30 AM

BUSINESS WIRE
RG6501 (OpRegen®) Preclinical Engraftment Results to Be Presented at 2024 Association for Research in Vision and Ophthalmology Meeting

03/11/2024 - 08:00 AM

BUSINESS WIRE
Graphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz Therapeutics

03/08/2024 - 05:00 PM

BUSINESS WIRE
Nordic Eyewear Market Insights & Forecasts Report 2024-2028 with Competitive Analysis of Grand Vision, Synsam, Specsavers, Synologen, Optik Team, and Krogh Optikk - ResearchAndMarkets.com

03/08/2024 - 07:12 AM

BUSINESS WIRE
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

03/07/2024 - 04:01 PM

BUSINESS WIRE
Nouveauté Suisse pour faciliter la sélection des lentilles dans la chirurgie de la cataracte

03/07/2024 - 10:30 AM

BUSINESS WIRE
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03/06/2024 - 04:01 PM

BUSINESS WIRE
MediPrint® Ophthalmics Announces Successful Completion of Its Phase 2b Glaucoma Clinical Study with Positive Results.

03/06/2024 - 01:15 PM

BUSINESS WIRE
Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone

03/06/2024 - 09:55 AM

BUSINESS WIRE

1 2 3

Next »

Search